Resources Contact Us Home
Assay for methylation in the GST-Pi gene

Image Number 10 for United States Patent #8088577.

A diagnostic or prognostic assay is disclosed for a disease of condition characterized by abnormal methylation of cytosine at side or sites within the glutathione-S-transferase (GST) Pi gene and/or its regulatory flanking sequences (e.g., prostate cancer and liver cancer). The assay comprises: (i) isolating DNA from said subject, and (ii) determining (e.g., by selective PCR amplification) the presence of abnormal methylation of cytosine at a site or sites within the GST-Pi gene and/or its regulatory flanking sequences.

  Recently Added Patents
N-phenyl-(homo)piperazinyl-benzenesulfonyl or benzenesulfonamide compounds suitable for treating disorders that respond to the modulation of the serotonin 5-HT.sub.6 receptor
Spreading technique applied to broadband mobile communications by satelite relying on DVB-RCS
Use of Lactobacillus for liver protection
Solid-state image sensing device and control method of solid-state image sensing device
Touch sensing technology
Efficient relay automatic repeat request procedure in broadband wireless access system
Method and CTDevice for computer tomographic spiral scanning of a patient
  Randomly Featured Patents
Gas/liquid contacting, perforated tray assembly
Logic support chip for AT-type computer with improved bus architecture
Method for increasing a very-large-scale-integrated (VLSI) capacitor size on bulk silicon and silicon-on-insulator (SOI) wafers and structure formed thereby
Multi-functional office business machine
Process for the preparation of [1R-(1.beta.(R*), 3a.alpha., 4.beta., 7a.beta.)] octahydro-1-(5-hydroxy-1,5-dimethylhexyl)-7a-methyl-4H-inden-4-one
Crop drying (food preserving) apparatus
Internal ported band pass enclosure for sound cancellation
Explosive detection system and sample collecting device